CLSI M59
Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 2nd Edition, M59Ed2E
standard by Clinical and Laboratory Standards Institute, 01/01/2018
CLSI H57-A
Protocol for the Evaluation, Validation, and Implementation of Coagulometers; Approved Guideline, H57-A
standard by Clinical and Laboratory Standards Institute, 01/01/2008
CLSI H48-A
Determination of Factor Coagulant Activities; Approved Guideline
standard by Clinical and Laboratory Standards Institute, 04/01/1997
CLSI H47-A2
One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline – Second Edition., H47-A2
standard by Clinical and Laboratory Standards Institute, 01/01/2008
CLSI MM07-A2 (R2018)
Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline–Second Edition, MM07A2E
standard by Clinical and Laboratory Standards Institute, 08/30/2013
CLSI EP29-A
Expression of Measurement Uncertainty in Laboratory Medicine; Approved Guideline, EP29AE
standard by Clinical and Laboratory Standards Institute, 01/01/2012
CLSI LIS07-A
Standard Specification for Use of Bar Codes on Specimen Tubes in the Clinical Laboratory, LIS7AE
standard by Clinical and Laboratory Standards Institute, 04/20/2003
CLSI M28-A2
Procedures for the Recovery and Identification of Parasites From the Intestinal Tract; Approved Guideline, M28A2E
standard by Clinical and Laboratory Standards Institute, 06/30/2005
CLSI POCT01-P
Implementation Guide of POCT1 for Healthcare Providers; Proposed Guideline, POCT1-P
standard by Clinical and Laboratory Standards Institute, 01/01/2007
CLSI VET03
Methods for Antimicrobial Broth Dilution and Disk Diffusion Susceptibility Testing of Bacteria Isolated From Aquatic Animals, 2nd Edition, VET03Ed2E
standard by Clinical and Laboratory Standards Institute, 05/20/2020